Rational design of boropeptide thrombin inhibitors with greater selectivity over complement factor I - Fevig, J M; Buriak, J; Cacciola, J; Alexender, R S; Kettner, C A; Knabb, R M; Pruitt, J R; Thoolen, M J; Weber, P; Wexler, R R (In “Abstracts of the 212thAmerican Chemical Society National Meeting, Division of Medicinal Chemistry”, 1996)
n°